Preparation of sub-visual molecular aggregrates composed of antimony
phosphate derivatives
    13.
    发明授权
    Preparation of sub-visual molecular aggregrates composed of antimony phosphate derivatives 失效
    由磷酸锑衍生物组成的亚视觉分子聚集体的制备

    公开(公告)号:US6010977A

    公开(公告)日:2000-01-04

    申请号:US103785

    申请日:1998-06-24

    Inventor: Cheuk Chung Yau

    Abstract: The present invention relates to a process comprises mixing, at temperatures between about about 90.degree. C. to 300.degree. C., a first reactant solution comprising less than about 5.times.10.sup.-3 moles/l of at least one antimony compound and at least one first diol having having 2 to about 16 carbon atoms with a second reactant solution comprising less than about 30.times.10.sup.-3 moles/l of at least one phosphorus stabilizer compound and at least one second diol to form sub-visual molecular aggregates comprising antimony phosphate derivatives. Sub-visual molecular aggregates comprising antimony phosphate derivatives which are stable in suspension are also disclosed.

    Abstract translation: 本发明涉及一种方法,包括在约90℃至300℃的温度下混合包含小于约5×10-3摩尔/升至少一种锑化合物的第一反应物溶液和至少一种第一 具有2至约16个碳原子的二醇,第二反应物溶液包含小于约30×10 -3摩尔/升的至少一种磷稳定剂化合物和至少一种第二二醇,以形成包含磷酸锑衍生物的亚视觉分子聚集体。 还公开了包含悬浮液中稳定的磷酸锑衍生物的亚视觉分子聚集体。

    Transition metal complexes for enantioselective catalysis of carbon-carbon, carbon-heteroatom, and carbon-hydrogen bond forming reactions
    17.
    发明授权
    Transition metal complexes for enantioselective catalysis of carbon-carbon, carbon-heteroatom, and carbon-hydrogen bond forming reactions 有权
    用于碳 - 碳,碳 - 杂原子和碳 - 氢键形成反应的对映选择性催化的过渡金属络合物

    公开(公告)号:US09446393B2

    公开(公告)日:2016-09-20

    申请号:US14417655

    申请日:2013-07-29

    Abstract: In some embodiments, the present disclosure pertains to a compound, comprising a transition metal complex having the formula Φ-[M(x,y)-L1(w,v)-L2(t,u)-L3]p+An−mZ−p_m. In an embodiment of the present disclosure Φ may be A. In another embodiment Φ may be Δ. In some embodiments of the present disclosure, M is a transition metal. In a related embodiment, p is an integer corresponding to the oxidation state of M. In some embodiments of the present disclosure, each of x, y, w, v, t, and u independently comprise R. In other embodiments, each of x, y, w, v, t, and u independently comprise S. In an embodiment of the present disclosure, each of L1, L2, and L3 independently is a ligand comprising a substituted diamine. In some embodiments, An″ comprises a lipophilic anion, where m is from 1 to 3, and where Z− comprises an optional second anion.

    Abstract translation: 在一些实施方案中,本公开涉及包含具有式Φ-[M(x,y)-L1(w,v)-L2(t,u)-L3] p + An- mZ-p_m。 在本公开的实施例中,Φ可以是A.在另一个实施例中,Φ可以是Δ。 在本公开的一些实施方案中,M是过渡金属。 在相关实施方案中,p是对应于M的氧化态的整数。在本公开的一些实施方案中,x,y,w,v,t和u中的每一个独立地包含R.在其它实施方案中,x ,y,w,v,t和u独立地包括S.在本公开的实施方案中,L1,L2和L3中的每一个独立地为包含取代的二胺的配体。 在一些实施方案中,An“包含亲脂性阴离子,其中m为1至3,并且其中Z-包含任选的第二阴离子。

Patent Agency Ranking